Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Pattern of remyelination in the CNS.
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus.
Multiple sclerosis review.
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
Clinical proteomics of enervated neurons.
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
PML in a patient treated with fumaric acid.
Biogen Idec reports death of patient on its MS pill
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
The cell biology of CNS myelination.
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Headwaters of the zebrafish -- emergence of a new model vertebrate.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Neurological involvement in Primary Sjögren Syndrome.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.

Pages